Sanofi (SNY)
46.96
+0.20
(+0.43%)
USD |
NASDAQ |
Apr 13, 16:00
47.08
+0.12
(+0.26%)
After-Hours: 07:05
Sanofi Cash from Investing (TTM) : -2.854B for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Cellectis SA | -29.58M |
| Novavax, Inc. | -78.27M |
| Regeneron Pharmaceuticals, Inc. | -629.10M |
| BioNTech SE | -2.797B |
| Moderna, Inc. | 1.946B |